WILMINGTON, MASSACHUSETTS--(Marketwire - February 13, 2008) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced that Bob Doman, President & Chief Executive Officer will present at the Roth Capital Partners 20th Annual Growth Stock Conference. The conference is being held at The Ritz Carlton Laguna Niguel, Dana Point, California February 18-22, 2008. Mr. Doman is scheduled to present at 1:00 p.m. Pacific Time (4:00 p.m. Eastern Time) on Wednesday, February 20.
